XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.1
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Earnings
Balance beginning of period (in shares) at Dec. 31, 2020   54,773      
Balance beginning of period at Dec. 31, 2020 $ 1,341,551 $ 548 $ 582,749 $ (211,477) $ 969,731
Increase (Decrease) in Stockholders' Equity          
Net income 21,736       21,736
Other comprehensive income 11,948     11,948  
Stock-based compensation 3,480   3,480    
Issuance of common stock for restricted share vesting, net of employee tax withholdings (in shares)   78      
Issuance of common stock for restricted share vesting, net of employee tax withholdings (3,719) $ 1 (3,720)    
Repurchases of common stock (in shares)   (300)      
Repurchases of common stock (26,546) $ (3) (26,543)    
Balance ending of period (in shares) at Mar. 31, 2021   54,551      
Balance ending of period at Mar. 31, 2021 1,348,450 $ 546 555,966 (199,529) 991,467
Balance beginning of period (in shares) at Dec. 31, 2021   54,419      
Balance beginning of period at Dec. 31, 2021 1,513,887 $ 544 536,377 (196,012) 1,172,978
Increase (Decrease) in Stockholders' Equity          
Net income 45,314       45,314
Other comprehensive income 33,849     33,849  
Stock-based compensation 5,712   5,712    
Issuance of common stock for restricted share vesting, net of employee tax withholdings (in shares)   36      
Issuance of common stock for restricted share vesting, net of employee tax withholdings (1,831)   (1,831)    
Repurchases of common stock (in shares)   (41)      
Repurchases of common stock (3,694)   (3,694)    
Balance ending of period (in shares) at Mar. 31, 2022   54,414      
Balance ending of period at Mar. 31, 2022 $ 1,593,237 $ 544 $ 536,564 $ (162,163) $ 1,218,292